Cochrane · systematic review · CD009227

Flupenthixol versus low‐potency first‐generation antipsychotic drugs for schizophrenia

Tardy, M, Dold, M, Engel, RR, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

SchizophreniaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
0
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 7 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

FLUPENTHIXOL versus LOW‐POTENCY ANTIPSYCHOTICS for schizophrenia

Population: patients with schizophrenia
7 questions
OutcomeEffectEvidenceStatus / GRADE
Response to treatment
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Acceptability to treatment ‐ leaving the study early due to any reason
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Adverse effects ‐ at least one adverse effect
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Adverse effects ‐ at least one movement disorder
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Adverse effects ‐ sedation
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Adverse effects ‐ death
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded
Quality of life
FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTICS
no estimate extracted0 studies · 0 participantsUngraded